Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × temsirolimus × 90 days × Clear all

Sponsor

Conditions

Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Sarcoma 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdomyosarcoma 1 PRETEXT I Hepatoblastoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Desmoplastic Small Round Cell Tumor 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Advanced Cancer 1 Adult Solid Neoplasm 1

Interventions

Nivolumab 8 pembrolizumab 7 avelumab 5 Specimen Handling 5 Biopsy 5 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 cemiplimab 2 atezolizumab 2 aldesleukin 2 Radiotherapy 2 Immunoglobulin G 2 Cyclophosphamide 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1 regorafenib 1 prednylidene 1 poly ICLC 1 fludarabine phosphate 1 fludarabine 1 flt3 ligand protein 1 durvalumab 1 deltacortene 1 decitabine and cedazuridine drug combination 1 aflibercept 1 X-Rays 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡